NCT05729737View on ClinicalTrials.gov

Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

January 31, 2026

Conditions
Pancreatic CancerUltrasonographyFirst-line Chemotherapy
Interventions
DIAGNOSTIC_TEST

Contrast-enhanced ultrasound(CEUS)

CEUS is a quantitative kinetic imaging modality that can assess intravascular blood flow in pancreatic tumors, it is safe and widely used in liver and pancreatic disease.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER